CN102558193B - 藤黄精酸衍生物及其制备方法和应用 - Google Patents
藤黄精酸衍生物及其制备方法和应用 Download PDFInfo
- Publication number
- CN102558193B CN102558193B CN201210014980.1A CN201210014980A CN102558193B CN 102558193 B CN102558193 B CN 102558193B CN 201210014980 A CN201210014980 A CN 201210014980A CN 102558193 B CN102558193 B CN 102558193B
- Authority
- CN
- China
- Prior art keywords
- gamboge
- essence
- group
- alkyl
- acid derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C**(*)N(C)* Chemical compound C**(*)N(C)* 0.000 description 1
- SIOJFSPPXXFDMK-UHFFFAOYSA-N COCCCN(CC1)CC1OC Chemical compound COCCCN(CC1)CC1OC SIOJFSPPXXFDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
Description
浓度 | 10-4M | 10-5M | 10-6M | 10-7M | 10-8M | 效果 |
藤黄精酸 | 100 | 100 | 5 | 0 | 0 | 弱效 |
6-甲氧基藤黄精酸甲酯 | 100 | 100 | 100 | 0 | 0 | 强效 |
藤黄精酸乙酯 | 100 | 100 | 98 | 0 | 0 | 强效 |
6-乙氧基藤黄精酸乙酯 | 100 | 100 | 94 | 0 | 0 | 强效 |
6-乙酰藤黄精酸 | 100 | 100 | 96 | 0 | 0 | 强效 |
藤黄精酰哌啶 | 100 | 100 | 70 | 0 | 0 | 弱效 |
藤黄精酰二乙胺 | 100 | 100 | 100 | 23 | 0 | 强效 |
藤黄精酰吗啡啉 | 100 | 100 | 100 | 14 | 0 | 强效 |
12-羟基藤黄精酸 | 100 | 100 | 100 | 0 | 0 | 强效 |
8,9-环氧藤黄精酸 | 100 | 100 | 100 | 0 | 0 | 强效 |
浓度 | 10-4M | 10-5M | 10-6M | 10-7M | 10-8M | 效果 |
藤黄精酸 | 100 | 100 | 0 | 0 | 0 | 弱效 |
6-甲氧基藤黄精酸甲酯 | 100 | 100 | 80 | 0 | 0 | 强效 |
藤黄精酸乙酯 | 100 | 100 | 96 | 0 | 0 | 强效 |
6-乙氧基藤黄精酸乙酯 | 100 | 100 | 86 | 0 | 0 | 强效 |
6-乙酰藤黄精酸 | 100 | 100 | 83 | 0 | 0 | 强效 |
藤黄精酰哌啶 | 100 | 100 | 67 | 0 | 0 | 弱效 |
藤黄精酰二乙胺 | 100 | 100 | 84 | 0 | 0 | 强效 |
藤黄精酰吗啡啉 | 100 | 100 | 78 | 14 | 0 | 强效 |
12-羟基藤黄精酸 | 100 | 100 | 82 | 0 | 0 | 强效 |
8,9-环氧藤黄精酸 | 100 | 100 | 80 | 0 | 0 | 强效 |
Claims (6)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210014980.1A CN102558193B (zh) | 2012-01-18 | 2012-01-18 | 藤黄精酸衍生物及其制备方法和应用 |
JP2014541517A JP6226871B2 (ja) | 2012-01-18 | 2012-09-28 | ガンボジェニック酸誘導体及びその調製方法と使用 |
US14/354,839 US9187491B2 (en) | 2012-01-18 | 2012-09-28 | Gambogenic acid derivatives, preparation method and application thereof |
EP12865912.5A EP2805956B1 (en) | 2012-01-18 | 2012-09-28 | Gambogenic acid derivatives, preparation method and application thereof |
PCT/CN2012/082306 WO2013107189A1 (zh) | 2012-01-18 | 2012-09-28 | 藤黄精酸衍生物及其制备方法和应用 |
RU2014130249/04A RU2598032C2 (ru) | 2012-01-18 | 2012-09-28 | Производные гамбогеновой кислоты, способ их получения и применение |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210014980.1A CN102558193B (zh) | 2012-01-18 | 2012-01-18 | 藤黄精酸衍生物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102558193A CN102558193A (zh) | 2012-07-11 |
CN102558193B true CN102558193B (zh) | 2014-12-17 |
Family
ID=46404938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210014980.1A Active CN102558193B (zh) | 2012-01-18 | 2012-01-18 | 藤黄精酸衍生物及其制备方法和应用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9187491B2 (zh) |
EP (1) | EP2805956B1 (zh) |
JP (1) | JP6226871B2 (zh) |
CN (1) | CN102558193B (zh) |
RU (1) | RU2598032C2 (zh) |
WO (1) | WO2013107189A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558193B (zh) * | 2012-01-18 | 2014-12-17 | 上海交通大学医学院附属第九人民医院 | 藤黄精酸衍生物及其制备方法和应用 |
CN103304575B (zh) * | 2012-03-14 | 2016-04-20 | 何黎琴 | 新藤黄酸衍生物、其制备方法及医药用途 |
CN104447786B (zh) * | 2014-12-17 | 2016-08-24 | 中国药科大学 | 一类藤黄属三氮唑衍生物、其制备方法和医药用途 |
CN105131011B (zh) * | 2015-09-01 | 2017-08-25 | 中国药科大学 | 氨基甲酸酯桥环呫吨酮衍生物、其制备方法和医药用途 |
CN105367575B (zh) * | 2015-12-03 | 2017-03-29 | 何黎琴 | 一种叶酸类化合物、其制备方法及医药用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044216A2 (en) * | 1999-02-01 | 2000-08-03 | Cytovia Inc | Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
CN1715283A (zh) * | 2004-07-02 | 2006-01-04 | 中国科学院上海药物研究所 | 新藤黄酸衍生物及其制备方法和用途 |
CN1738620A (zh) * | 2002-07-01 | 2006-02-22 | 西托维亚公司 | 作为半胱天冬酶激活剂和细胞调亡诱导剂的藤黄酸衍生物及其类似物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462041B1 (en) * | 1999-05-21 | 2002-10-08 | Cytovia, Inc. | Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
DE29923419U1 (de) * | 1999-07-01 | 2001-02-08 | Asta Medica Ag | Neue Xanthonverbindungen und diese enthaltende Arzneimittel |
US7622497B2 (en) * | 2003-12-18 | 2009-11-24 | Cytovia, Inc. | Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
CN1718183A (zh) | 2005-04-22 | 2006-01-11 | 王效山 | 一种注射用新藤黄酸制剂及其制备方法、应用 |
CN1718184A (zh) | 2005-04-22 | 2006-01-11 | 王效山 | 具有抗肿瘤活性的新藤黄酸复合物、制备方法及其制剂和用途 |
CN101947204B (zh) | 2010-07-21 | 2013-01-02 | 彭代银 | 新藤黄酸固体脂质纳米粒及其制备方法 |
CN102558193B (zh) * | 2012-01-18 | 2014-12-17 | 上海交通大学医学院附属第九人民医院 | 藤黄精酸衍生物及其制备方法和应用 |
-
2012
- 2012-01-18 CN CN201210014980.1A patent/CN102558193B/zh active Active
- 2012-09-28 EP EP12865912.5A patent/EP2805956B1/en active Active
- 2012-09-28 JP JP2014541517A patent/JP6226871B2/ja active Active
- 2012-09-28 US US14/354,839 patent/US9187491B2/en active Active
- 2012-09-28 WO PCT/CN2012/082306 patent/WO2013107189A1/zh active Application Filing
- 2012-09-28 RU RU2014130249/04A patent/RU2598032C2/ru active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044216A2 (en) * | 1999-02-01 | 2000-08-03 | Cytovia Inc | Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
CN1738620A (zh) * | 2002-07-01 | 2006-02-22 | 西托维亚公司 | 作为半胱天冬酶激活剂和细胞调亡诱导剂的藤黄酸衍生物及其类似物 |
CN1715283A (zh) * | 2004-07-02 | 2006-01-04 | 中国科学院上海药物研究所 | 新藤黄酸衍生物及其制备方法和用途 |
Non-Patent Citations (1)
Title |
---|
Five novel prenylated xanthones from Resina Garciniae;FENG FENG et al.;《Journal of Asian Natural Products Research》;20071231;第9卷(第8期);735–741 * |
Also Published As
Publication number | Publication date |
---|---|
RU2014130249A (ru) | 2016-03-10 |
WO2013107189A1 (zh) | 2013-07-25 |
RU2598032C2 (ru) | 2016-09-20 |
US9187491B2 (en) | 2015-11-17 |
JP6226871B2 (ja) | 2017-11-08 |
EP2805956A1 (en) | 2014-11-26 |
CN102558193A (zh) | 2012-07-11 |
JP2015502348A (ja) | 2015-01-22 |
EP2805956B1 (en) | 2018-12-26 |
EP2805956A4 (en) | 2015-05-27 |
US20140309418A1 (en) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102558193B (zh) | 藤黄精酸衍生物及其制备方法和应用 | |
Lin et al. | Xanthone derivatives as potential anti-cancer drugs | |
CN102153564B (zh) | 含氮原子的青蒿素二聚体、其制备方法及用途 | |
CN101857583A (zh) | 异黄酮类金属配合物制备方法及抗肿瘤医药用途 | |
CN103467474B (zh) | 1,6,7,14-位取代的冬凌草甲素衍生物、制备方法及用途 | |
CN104119330B (zh) | 小檗碱衍生物的合成及其在制备抗肿瘤药物和协同阿霉素抗肿瘤药物组合物中的应用 | |
WO2013178021A1 (zh) | 吡咯并[2,1—f][1,2,4]三嗪衍生物及其抗肿瘤用途 | |
CN106543209A (zh) | 邻菲罗啉衍生物的铜配合物及其制备方法和应用 | |
TW200303867A (en) | Novel farnesyl protein transferase inhibitors as antitumor agents | |
CN103275106B (zh) | 一种吲哚生物碱加合物及其制备方法和在制备抗肿瘤药物中的应用 | |
CN103570790B (zh) | 原人参二醇衍生物及其制备方法、包含该衍生物的组合物及其用途 | |
CN100357264C (zh) | 一种查尔酮肟及其组合物、制备方法和应用 | |
CN103864957A (zh) | 基于环糊精载体的青蒿素前药及其制备方法 | |
CN102584679B (zh) | 一类苯并咔唑酰胺类化合物、其制备方法和用途 | |
CN102949388A (zh) | 异黄酮类成分及其制备的药物 | |
CN102731454A (zh) | 去氢木香烃内酯衍生物,其药物组合物及其制备方法和用途 | |
CN103421028B (zh) | 长春瑞滨衍生物、其药物组合物及其制备方法和用途 | |
CN110627615B (zh) | β-榄香烯氧化物及制备方法和用途 | |
CN106187985B (zh) | 具有抗乳腺癌活性的苯并香豆素类化合物及其制备方法 | |
CN101590035B (zh) | 异戊烯基取代的脱氢水飞蓟宾双醚化合物在制备抗癌药物中的应用 | |
CN109734715A (zh) | 一类高效的dna靶向抗肿瘤药物及其合成方法和应用 | |
CN105367575A (zh) | 一种叶酸类化合物、其制备方法及医药用途 | |
CN101735238B (zh) | 抗肿瘤药物羟地吗啉和其衍生物及制备方法和应用 | |
CN104003998A (zh) | 冬凌草甲素14-o-取代氮芥衍生物、制备方法及用途 | |
CN115838386A (zh) | 一种芦竹碱-铂(iv)配合物的制备方法及其在肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Wantao Inventor after: Pan Jinsong Inventor after: Lv Yan Inventor after: Deng Rongxin Inventor after: Qiu Weiliu Inventor after: Wang Xu Inventor after: Zhang Zhiyuan Inventor after: Zhang Chenping Inventor after: Mao Li Inventor after: Zhang Ping Inventor after: Xu Qin Inventor after: Yan Ming Inventor after: Zhang Jianjun Inventor before: Chen Wantao Inventor before: Wang Xu Inventor before: Pan Jinsong Inventor before: Xu Qin Inventor before: Yan Ming Inventor before: Lv Yan Inventor before: Deng Rongxin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN WANTAO WANG XU PAN JINSONG XU YAN MING LV YAN DENG RONGXIN TO: CHENWANTAO WANG XU ZHANG ZHIYUAN ZHANG CHENPING MAO LI ZHANG PING XU YAN MING ZHANG JIANJUN PAN JINSONG LV YAN DENG RONGXIN QIU WEILIU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |